Cambridge Investment Research Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Sell |
13,566
-16,155
| -54% | -$428K | ﹤0.01% | 2834 |
|
|
2025
Q1 | $718K | Buy |
29,721
+16,302
| +121% | +$394K | ﹤0.01% | 2141 |
|
|
2024
Q4 | $540K | Sell |
13,419
-28,970
| -68% | -$1.17M | ﹤0.01% | 2367 |
|
|
2024
Q3 | $2.68M | Buy |
42,389
+17,261
| +69% | +$1.09M | 0.01% | 1147 |
|
|
2024
Q2 | $1.33M | Buy |
25,128
+10,447
| +71% | +$554K | ﹤0.01% | 1573 |
|
|
2024
Q1 | $1.2M | Buy |
+14,681
| New | +$1.2M | ﹤0.01% | 1605 |
|
|
2023
Q3 | – | Sell |
-13,741
| Closed | -$223K | – | 3270 |
|
|
2023
Q2 | $223K | Buy |
+13,741
| New | +$223K | ﹤0.01% | 2788 |
|
|
2023
Q1 | – | Sell |
-10,113
| Closed | -$95K | – | 3261 |
|
|
2022
Q4 | $95K | Sell |
10,113
-701
| -6% | -$6.59K | ﹤0.01% | 2920 |
|
|
2022
Q3 | $29K | Sell |
10,814
-499
| -4% | -$1.34K | ﹤0.01% | 2984 |
|
|
2022
Q2 | $33K | Hold |
11,313
| – | – | ﹤0.01% | 2973 |
|
|
2022
Q1 | $34K | Hold |
11,313
| – | – | ﹤0.01% | 3101 |
|
|
2021
Q4 | $52K | Buy |
11,313
+200
| +2% | +$919 | ﹤0.01% | 3100 |
|
|
2021
Q3 | $70K | Buy |
11,113
+185
| +2% | +$1.17K | ﹤0.01% | 3001 |
|
|
2021
Q2 | $65K | Sell |
10,928
-3,135
| -22% | -$18.6K | ﹤0.01% | 3012 |
|
|
2021
Q1 | $89K | Buy |
+14,063
| New | +$89K | ﹤0.01% | 2772 |
|
|
2019
Q2 | – | Sell |
-14,275
| Closed | -$142K | – | 2361 |
|
|
2019
Q1 | $142K | Buy |
+14,275
| New | +$142K | ﹤0.01% | 2144 |
|